Literature DB >> 16142231

Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.

Yeong-Gwan Park1, Xiaohong Zhao, Fabienne Lesueur, Douglas R Lowy, Mindy Lancaster, Paul Pharoah, Xiaolan Qian, Kent W Hunter.   

Abstract

We previously identified loci in the mouse genome that substantially influence the metastatic efficiency of mammary tumors. Here, we present data supporting the idea that the signal transduction molecule, Sipa1, is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Analysis of candidate genes identified a nonsynonymous amino acid polymorphism in Sipa1 that affects the Sipa1 Rap-GAP function. Spontaneous metastasis assays using cells ectopically expressing Sipa1 or cells with knocked-down Sipa1 expression showed that metastatic capacity was correlated with cellular Sipa1 levels. We examined human expression data and found that they were consistent with the idea that Sipa1 concentration has a role in metastasis. Taken together, these data suggest that the Sipa1 polymorphism is one of the genetic polymorphisms underlying the Mtes1 locus. This report is also the first demonstration, to our knowledge, of a constitutional genetic polymorphism affecting tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142231      PMCID: PMC2140048          DOI: 10.1038/ng1635

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  66 in total

1.  A molecular signature of metastasis in primary solid tumors.

Authors:  Sridhar Ramaswamy; Ken N Ross; Eric S Lander; Todd R Golub
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

2.  The mosaic structure of variation in the laboratory mouse genome.

Authors:  Claire M Wade; Edward J Kulbokas; Andrew W Kirby; Michael C Zody; James C Mullikin; Eric S Lander; Kerstin Lindblad-Toh; Mark J Daly
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

Review 3.  Metastasis suppressors alter the signal transduction of cancer cells.

Authors:  Patricia S Steeg
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

4.  Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse.

Authors:  K Lindblad-Toh; E Winchester; M J Daly; D G Wang; J N Hirschhorn; J P Laviolette; K Ardlie; D E Reich; E Robinson; P Sklar; N Shah; D Thomas; J B Fan; T Gingeras; J Warrington; N Patil; T J Hudson; E S Lander
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

5.  Genealogies of mouse inbred strains.

Authors:  J A Beck; S Lloyd; M Hafezparast; M Lennon-Pierce; J T Eppig; M F Festing; E M Fisher
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

6.  An intronic polymorphic repeat sequence modulates interleukin-1 alpha gene regulation.

Authors:  S Bailly; N Israël; M Fay; M A Gougerot-Pocidalo; G W Duff
Journal:  Mol Immunol       Date:  1996-08       Impact factor: 4.407

Review 7.  From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century.

Authors:  B Fisher
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

8.  Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.

Authors:  R Heimann; F Lan; R McBride; S Hellman
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

9.  Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice.

Authors:  K A Gould; C Luongo; A R Moser; M K McNeley; N Borenstein; A Shedlovsky; W F Dove; K Hong; W F Dietrich; E S Lander
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

10.  Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.

Authors:  M E Miele; G Robertson; J H Lee; A Coleman; C T McGary; P B Fisher; T G Lugo; D R Welch
Journal:  Mol Carcinog       Date:  1996-04       Impact factor: 4.784

View more
  84 in total

1.  Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.

Authors:  Anne Masset; Catherine Maillard; Nor Eddine Sounni; Nathalie Jacobs; Françoise Bruyére; Philippe Delvenne; Marlene Tacke; Thomas Reinheckel; Jean-Michel Foidart; Lisa M Coussens; Agnès Noël
Journal:  Int J Cancer       Date:  2010-03-15       Impact factor: 7.396

2.  Integrated cross-species transcriptional network analysis of metastatic susceptibility.

Authors:  Ying Hu; Gang Wu; Michael Rusch; Luanne Lukes; Kenneth H Buetow; Jinghui Zhang; Kent W Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Genome-wide discovery of functional transcription factor binding sites by comparative genomics: the case of Stat3.

Authors:  Francesco Vallania; Davide Schiavone; Sarah Dewilde; Emanuela Pupo; Serge Garbay; Raffaele Calogero; Marco Pontoglio; Paolo Provero; Valeria Poli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-12       Impact factor: 11.205

Review 4.  Systems genetics analysis of cancer susceptibility: from mouse models to humans.

Authors:  David Quigley; Allan Balmain
Journal:  Nat Rev Genet       Date:  2009-07-28       Impact factor: 53.242

Review 5.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

6.  Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk.

Authors:  Karlyne M Reilly
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

7.  No evidence of familial correlation in breast cancer metastasis.

Authors:  Alice S Whittemore; Beth Stearman; Vickie Venne; Jerry Halpern; Anna Felberg; Valerie McGuire; Mary Daly; Saundra S Buys
Journal:  Breast Cancer Res Treat       Date:  2009-03-19       Impact factor: 4.872

Review 8.  Mouse modifier genes in mammary tumorigenesis and metastasis.

Authors:  Scott F Winter; Kent W Hunter
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-26       Impact factor: 2.673

9.  Genotype X diet interactions in mice predisposed to mammary cancer: II. Tumors and metastasis.

Authors:  Ryan R Gordon; Kent W Hunter; Michele La Merrill; Peter Sørensen; David W Threadgill; Daniel Pomp
Journal:  Mamm Genome       Date:  2008-02-21       Impact factor: 2.957

Review 10.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.